共 50 条
- [41] CLINICAL TRIAL OF 5-HYDROXYPICOLINALDEHYDE THIOSEMICARBAZONE (5-HP - NSC-107392), WITH SPECIAL REFERENCE TO ITS IRON-CHELATING PROPERTIES CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (02): : 207 - 212
- [47] Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties GENES AND NUTRITION, 2009, 4 (04): : 283 - 296
- [48] Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties Genes & Nutrition, 2009, 4 : 283 - 296
- [49] CELL-CYCLE KINETICS OF CHINESE-HAMSTER (CHO) CELLS TREATED WITH THE IRON-CHELATING AGENT PICOLINIC-ACID CELL AND TISSUE KINETICS, 1981, 14 (03): : 269 - 283